Insights

News

General
Celonic is proud to support process optimization and GMP manufacturing of a novel COVID19 therapeutic candidate – Airway Therapeutics ‘ AT-100
May 22, 2020
General
Celonic business continuity statement
March 23, 2020
Appointments
Dr. Marc Arnold is appointed as the Vice-President Biologics Development at Celonic’s headquarters
January 28, 2019
General
Celonic AG Partners with Sparta to Improve Quality and Deliver Higher Customer Satisfaction
December 20, 2018
Appointments
Dr. Jacky Schmitt takes over the leadership of production as Vice-President of Production at Celonic Group’s sites
December 1, 2018
General
Cutting time to market for high quality therapeutics
Scientific article, Sebastian Lambert, Senior Scientist, Celonic
September 19, 2018
General
Opportunities and future growth of the CDMO market
Interview, Dr. Konstantin Matentzoglu, CEO Celonic Group
May 23, 2018
Appointments, Cell & Gene therapy
Soenke Brunswieck, new Vice President Cell & Gene Therapy
Press release, b3C newswire
May 8, 2018
General
Celonic’s expansion strategy into commercial supply space
Interview, Dr. Franzpeter Bracht, COO Celonic
March 12, 2018
Growth Investments
Celonic Acquires Glycotope’s bio-manufacturing Facility
Press release, b3C newswire
November 3, 2017
General
Merck expands Celonic’s upstream capabilities
Press release, https://www.merckgroup.com
September 13, 2017
General
Celonic the CDMO partner of choice in Switzerland and beyond
Interview, Dr.Konstantin Matentzoglu, CEO Celonic
February 2, 2017
General
Subsidiary Heidelberg Pharma contracts Suisse CDMO Celonic
In Munich, Germany
September 27, 2016